Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma

por Russo, Irene, Zorzetto, Ludovica, Chiarion Sileni, Vanna, Alaibac, Mauro
Publicado en Scientifica (Cairo) (2018)

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib

por Valpione, Sara, Campana, Luca G., Pigozzo, Jacopo, Chiarion-Sileni, Vanna
Publicado en Radiol Oncol (2015)

Systemic treatments for metastatic cutaneous melanoma

por Pasquali, Sandro, Hadjinicolaou, Andreas V, Chiarion Sileni, Vanna, Rossi, Carlo Riccardo, Mocellin, Simone
Publicado en Cochrane Database Syst Rev (2018)

Predictors of toxicity for metastatic melanoma patients treated with ipilimumab

por Valpione, Sara, Pasquali, Sandro, Campana, Luca, Mocellin, Simone, Piccin, Luisa, Pigozzo, Jacopo, Chiarion-Sileni, Vanna
Publicado en J Immunother Cancer (2015)

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade

por Valpione, Sara, Pasquali, Sandro, Campana, Luca Giovanni, Piccin, Luisa, Mocellin, Simone, Pigozzo, Jacopo, Chiarion-Sileni, Vanna
Publicado en J Transl Med (2018)

Melanoma M (Zero): Diagnosis and Therapy

por Rastrelli, Marco, Alaibac, Mauro, Stramare, Roberto, Chiarion Sileni, Vanna, Montesco, Maria Cristina, Vecchiato, Antonella, Campana, Luca Giovanni, Rossi, Carlo Riccardo
Publicado 2013

Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study

por Boldrin, Elisa, Rumiato, Enrica, Fassan, Matteo, Cappellesso, Rocco, Rugge, Massimo, Chiarion-Sileni, Vanna, Ruol, Alberto, Alfieri, Rita, Cagol, Matteo, Castoro, Carlo, Amadori, Alberto, Saggioro, Daniela
Publicado en PLoS One (2015)

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-g...

por Chiarion-Sileni, Vanna, Del Bianco, Paola, Romanini, Antonella, Guida, Michele, Paccagnella, Adriano, Dalla Palma, Maurizio, Naglieri, Emanuele, Ridolfi, Ruggero, Silvestri, Barbara, Michiara, Maria, De Salvo, Gian Luca
Publicado 2006

A gene expression signature associated with survival in metastatic melanoma

por Mandruzzato, Susanna, Callegaro, Andrea, Turcatel, Gianluca, Francescato, Samuela, Montesco, Maria C, Chiarion-Sileni, Vanna, Mocellin, Simone, Rossi, Carlo R, Bicciato, Silvio, Wang, Ena, Marincola, Francesco M, Zanovello, Paola
Publicado 2006

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma

por Valpione, Sara, Moser, Justin C., Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S., Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N., Aliberti, Camillo, Campana, Luca G., Chiarion-Sileni, Vanna
Publicado en PLoS One (2015)

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

por Maio, Michele, Grob, Jean-Jacques, Aamdal, Steinar, Bondarenko, Igor, Robert, Caroline, Thomas, Luc, Garbe, Claus, Chiarion-Sileni, Vanna, Testori, Alessandro, Chen, Tai-Tsang, Tschaika, Marina, Wolchok, Jedd D.
Publicado en J Clin Oncol (2015)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esopha...

por Fassan, Matteo, Cavallin, Francesco, Guzzardo, Vincenza, Kotsafti, Andromachi, Scarpa, Melania, Cagol, Matteo, Chiarion‐Sileni, Vanna, Maria Saadeh, Luca, Alfieri, Rita, Castagliuolo, Ignazio, Rugge, Massimo, Castoro, Carlo, Scarpa, Marco
Publicado en Cancer Med (2019)

Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients

por Rastrelli, Marco, Ferrazzi, Beatrice, Cavallin, Francesco, Chiarion Sileni, Vanna, Pigozzo, Jacopo, Fabozzi, Alessio, Tropea, Saveria, Vecchiato, Antonella, Costa, Alessandra, Parisi, Alessandro, Rossi, Carlo Riccardo, Del Fiore, Paolo, Alaibac, Mauro
Publicado en Cancers (Basel) (2018)

Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity

por Turato, Cristian, Scarpa, Melania, Kotsafti, Andromachi, Cappon, Andrea, Quarta, Santina, Biasiolo, Alessandra, Cavallin, Francesco, Trevellin, Elisabetta, Guzzardo, Vincenza, Fassan, Matteo, Chiarion‐Sileni, Vanna, Castoro, Carlo, Rugge, Massimo, Vettor, Roberto, Scarpa, Marco, Pontisso, Patrizia
Publicado en Cancer Sci (2019)

The cost of unresectable stage III or stage IV melanoma in Italy

por Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publicado 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado 2012

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

por Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publicado 2013

A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

por Rastrelli, Marco, Del Fiore, Paolo, Buja, Alessandra, Vecchiato, Antonella, Rossi, Carlo Riccardo, Chiarion Sileni, Vanna, Tropea, Saveria, Russano, Francesco, Zorzi, Manuel, Spina, Romina, Cappellesso, Rocco, Mazzarotto, Renzo, Cavallin, Francesco, Bassetto, Franco, Bezzon, Elisabetta, Ferrazzi, Beatrice, Alaibac, Mauro, Mocellin, Simone
Publicado en Front Oncol (2020)

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

por Queirolo, Paola, Spagnolo, Francesco, Ascierto, Paolo Antonio, Simeone, Ester, Marchetti, Paolo, Scoppola, Alessandro, Del Vecchio, Michele, Di Guardo, Lorenza, Maio, Michele, Di Giacomo, Anna Maria, Antonuzzo, Andrea, Cognetti, Francesco, Ferraresi, Virginia, Ridolfi, Laura, Guidoboni, Massimo, Guida, Michele, Pigozzo, Jacopo, Chiarion Sileni, Vanna
Publicado 2014

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized...

por Schadendorf, Dirk, Wolchok, Jedd D., Hodi, F. Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher D., Chesney, Jason, Robert, Caroline, Grossmann, Kenneth, McDermott, David, Walker, Dana, Bhore, Rafia, Larkin, James, Postow, Michael A.
Publicado en J Clin Oncol (2017)